PT - JOURNAL ARTICLE AU - Härter, Georg AU - Spinner, Christoph D. AU - Roider, Julia AU - Bickel, Markus AU - Krznaric, Ivanka AU - Grunwald, Stephan AU - Schabaz, Farhad AU - Gillor, Daniel AU - Postel, Nils AU - Mueller, Matthias C. AU - Müller, Markus AU - Römer, Katja AU - Schewe, Knud AU - Hoffmann, Christian TI - COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients AID - 10.1101/2020.04.28.20073767 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.28.20073767 4099 - http://medrxiv.org/content/early/2020/05/01/2020.04.28.20073767.short 4100 - http://medrxiv.org/content/early/2020/05/01/2020.04.28.20073767.full AB - Data on people living with human immunodeficiency virus (PLWH) in the current SARS-CoV-2 pandemic is still scarce. This case series of 33 PLWH patients with COVID-19 reveals symptoms and outcome in this special population. Three out of 32 patients with documented outcome died (9%). However, 91% of the patients recovered and 76% have been classified as mild cases, indicating that there is no excess morbidity and mortality among PLWH with symptomatic COVID-19. All patients were on antiretroviral treatment, of them 22 on tenofovir-containing regimen, and 4 on the protease inhibitor darunavir.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding available.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.